Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20386072rdf:typepubmed:Citationlld:pubmed
pubmed-article:20386072lifeskim:mentionsumls-concept:C0019169lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0021747lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0209738lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0524909lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:20386072lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:20386072pubmed:issue2lld:pubmed
pubmed-article:20386072pubmed:dateCreated2010-4-13lld:pubmed
pubmed-article:20386072pubmed:abstractTextLamivudine and interferon have been widely used for the treatment of patients with chronic HBV infection. Serum HBV RNA is detected during lamivudine therapy as a consequence of interrupted reverse transcription and because RNA replicative intermediates are unaffected by the drug. In this study, we aimed to determine the detectability of serum HBV RNA during sequential combination therapy of interferon and lamivudine.lld:pubmed
pubmed-article:20386072pubmed:languageenglld:pubmed
pubmed-article:20386072pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:citationSubsetIMlld:pubmed
pubmed-article:20386072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20386072pubmed:statusMEDLINElld:pubmed
pubmed-article:20386072pubmed:issn2040-2058lld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:KaoJia-HorngJ...lld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:ChenDing-Shin...lld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:LaiMing-YangM...lld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:ChayamaKazuak...lld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:LiuChun-JenCJlld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:YangSien-Sing...lld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:HuJui-TingJTlld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:HuangYi-WenYWlld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:TakahashiShoi...lld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:AbeHiromiHlld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:TsugeMasataka...lld:pubmed
pubmed-article:20386072pubmed:authorpubmed-author:HatakeyamaTsu...lld:pubmed
pubmed-article:20386072pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20386072pubmed:volume15lld:pubmed
pubmed-article:20386072pubmed:ownerNLMlld:pubmed
pubmed-article:20386072pubmed:authorsCompleteYlld:pubmed
pubmed-article:20386072pubmed:pagination177-84lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:meshHeadingpubmed-meshheading:20386072...lld:pubmed
pubmed-article:20386072pubmed:year2010lld:pubmed
pubmed-article:20386072pubmed:articleTitleDifferential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B.lld:pubmed
pubmed-article:20386072pubmed:affiliationLiver Unit, Cathay General Hospital Medical Center, Taipei, Taiwan.lld:pubmed
pubmed-article:20386072pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20386072pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:20386072pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed